The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Nechaeva G.I.

Omskaia gosudarstvennaia meditsinskaia akademiia

Gaisina E.A.

«Medical City» Multidisciplinary Clinical Medical Center, Tyumen, Russia

Druk I.V.

Omsk State Medical University, Omsk, Russia

Loginova E.N.

Omsk State Medical University, Omsk, Russia

Tereshchenko Yu.V.

Omsk State Medical Academy, Omsk, Russia, Omsk, Russia

Nadey E.V.

Omsk State Medical Academy, Omsk, Russia, Omsk, Russia

Bilevich O.A.

Omsk State Medical Academy, Omsk, Russia, Omsk, Russia

The role of meglumin sodium succinat infusions in reducing cardiovascular toxicity on cancer treatments

Authors:

Nechaeva G.I., Gaisina E.A., Druk I.V., Loginova E.N., Tereshchenko Yu.V., Nadey E.V., Bilevich O.A.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2019;8(6): 433‑439

Views: 6887

Downloaded: 79


To cite this article:

Nechaeva GI, Gaisina EA, Druk IV, Loginova EN, Tereshchenko YuV, Nadey EV, Bilevich OA. The role of meglumin sodium succinat infusions in reducing cardiovascular toxicity on cancer treatments. P.A. Herzen Journal of Oncology. 2019;8(6):433‑439. (In Russ.)
https://doi.org/10.17116/onkolog20198061433

Recommended articles:
Oxidative stress in the pathogenesis of chro­nic headache. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):35-40
Neuroprotective therapy for age-related macu­lar dege­neration. Russian Annals of Ophthalmology. 2024;(6):152-158
Neuroprotective therapy of glaucoma. Russian Annals of Ophthalmology. 2025;(1):83-90

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.